Normal
I am no expert but the initial cost is high for new drugs as the company recovers R&D costs. One the patent expires, generics tend to fill the space. Could be wrong but I that's how it generally works.[URL unfurl="true"]https://www.prnewswire.com/news-releases/deloittes-15th-annual-pharmaceutical-innovation-report-pharma-rd-returns-continue-upward-for-second-consecutive-year-302410138.html[/URL]
I am no expert but the initial cost is high for new drugs as the company recovers R&D costs. One the patent expires, generics tend to fill the space. Could be wrong but I that's how it generally works.
[URL unfurl="true"]https://www.prnewswire.com/news-releases/deloittes-15th-annual-pharmaceutical-innovation-report-pharma-rd-returns-continue-upward-for-second-consecutive-year-302410138.html[/URL]
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.
